SIGANasdaqPharmaceutical PreparationsFiscal year ends December 31
SIGA TECHNOLOGIES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.14−0.03 (-0.95%)
Close on Oct 19, 2026
- Market cap
- $225.72M
- P/E (TTM)
- –
- Dividend yield
- 19.11%
SIGA TECHNOLOGIES INC revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Sales and Supportive Services [Member] | $37.87M | $3.54M | $2.21M | $889.75K | $79.12M | $5.82M | $79.83M | $8.94M | $20.68M | $23.88M | $115.74M | $7.96M | 92.4% | -52.1% |
| Research and Development [Member] | $3.13M | $2.70M | $1.58M | $1.73M | $2.00M | $1.22M | $1.64M | $1.07M | $1.14M | $1.55M | $736.71K | $1.28M | 7.6% | +57.0% |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $28.03M | $6.24M | $3.79M | $2.62M | $81.12M | $1.22M | $70.34M | $9.17M | $18.78M | $17.45M | $104.27M | $1.41M | 68.4% | -65.4% |
| Non-US [Member] | $12.97M | $0 | $0 | $0 | $0 | $5.82M | $11.13M | $836.91K | $3.03M | $7.98M | $12.21M | $7.83M | 31.6% | – |
| Asia Pacific [Member] | $12.70M | – | $0 | $0 | $0 | – | $11.13M | $0 | $2.73M | – | $966.63K | $0 | 31.0% | – |
| EMEA [Member] | $272.54K | – | $0 | $0 | $0 | $0 | $0 | $836.91K | $301.75K | $7.24M | $11.24M | $7.83M | 0.7% | – |
| Canada | $0 | $0 | $0 | $0 | $0 | $5.82M | $0 | $0 | $0 | $737.68K | $0 | $0 | 0.0% | – |
| Other [Member] | – | – | – | – | – | – | – | – | – | – | $0 | $0 | – | – |
From the segment and revenue-disaggregation notes of Siga Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.